Benzinga | Oct 26, 2021 01:59PM EDT

WHO, On Covaxin Approval, Tells Benzinga The Technical Advisory Group 'met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine.'

WHO Says 'The [Technical Advisory Group] expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, 3 November.'